A medical board is evaluating a recently developed serum biomarker assay used to screen fo… — USMLE Step 2 CK

A medical board is evaluating a recently developed serum biomarker assay used to screen for early-stage pancreatic cancer. The biomarker is a continuous variable, and higher serum concentrations are associated with a greater likelihood of malignancy. The original diagnostic cutoff for a positive test was established to prioritize early detection in the general population. Following a one-year review, it is found that an unacceptable number of healthy patients are undergoing highly invasive confirmatory pancreatic biopsies due to false-positive assay results. To minimize the incidence of these unnecessary and risky procedures, the board decides to adjust the diagnostic cutoff value. Assuming the prevalence of pancreatic cancer in the screened population remains constant, which of the following pairs of changes in test characteristics will most likely occur as a direct result of this adjustment?

Increase in the false-negative rate and increase in the positive predictive valueCevap
B
Decrease in the false-negative rate and increase in the negative predictive value
C
Increase in sensitivity and decrease in the positive predictive value
D
Decrease in specificity and decrease in the negative predictive value
E
Decrease in the positive predictive value and increase in the negative predictive value

Cevap

Increase in the false-negative rate and increase in the positive predictive value

The medical board's objective is to decrease the number of unnecessary invasive biopsies, which requires reducing the number of false-positive results. To achieve this, the diagnostic cutoff for the biomarker must be raised (made more stringent, requiring a higher biomarker level to test positive). Raising the cutoff increases the test's specificity (fewer false positives) but inherently decreases its sensitivity (resulting in more false negatives). Because the false-negative rate is calculated as

1 - \text{Sensitivity}

, a decrease in sensitivity directly results in an increased false-negative rate. Furthermore, assuming disease prevalence remains constant, an increase in specificity decreases the proportion of false positives in the population, which mathematically increases the positive predictive value (PPV) of the test. Therefore, adjusting the cutoff to minimize unnecessary biopsies will increase both the false-negative rate and the PPV.

Adım Adım Çözüm

Identify the clinical objective from the vignette.

The medical board wants to reduce the number of unnecessary invasive biopsies, which are caused by false-positive test results.

Understanding the clinical goal is required to determine how the test threshold should be manipulated.

Determine the necessary adjustment to the diagnostic cutoff.

To decrease false positives, the test must become more specific. This is achieved by raising the cutoff value (requiring a higher biomarker concentration for a positive result).

Raising the threshold makes it harder to test positive, thereby reducing the false-positive rate and increasing specificity.

Analyze the trade-off effect on sensitivity and false negatives.

Because specificity increases, sensitivity must decrease. A decrease in sensitivity directly translates to an increase in the false-negative rate.

In any continuous biomarker test, sensitivity and specificity share an inverse relationship. If it is harder to test positive, more true cases will be missed.

Evaluate the impact on predictive values.

With a constant prevalence, an increase in specificity (fewer false positives) mathematically increases the positive predictive value (PPV). Conversely, the decreased sensitivity reduces the negative predictive value (NPV).

PPV heavily depends on the false-positive rate; reducing false positives increases the likelihood that a positive result is a true positive.

Anahtar Kavram

Adjusting a diagnostic test cutoff to reduce false positives requires increasing specificity (raising the threshold), which inherently decreases sensitivity (increasing the false-negative rate) and increases the positive predictive value (PPV).

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru